Thermo Fisher Scientific (TMO) Non-Current Assets (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Non-Current Assets for 18 consecutive years, with $89.8 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Assets rose 17.17% year-over-year to $89.8 billion; the trailing twelve-month figure through Jun 2026 stood at $343.1 billion (up 12.85% YoY), and the FY2025 full-year result was $81.6 billion, up 8.58% from the prior year.
• Non-Current Assets declined to $89.8 billion in Q2 2026 per TMO's latest filing, from $91.0 billion in the prior quarter.
• Across five years, Non-Current Assets topped out at $91.0 billion in Q1 2026 and bottomed at $71.2 billion in Q4 2022.
• Historically, Non-Current Assets has averaged $76.7 billion across 5 years, with a median of $74.3 billion in 2023.
• The widest YoY moves for Non-Current Assets: up 53.32% in 2022, down 4.11% in 2022.
• Over 5 years, Non-Current Assets stood at $71.9 billion in 2022, then climbed by 3.08% to $74.1 billion in 2023, then increased by 1.41% to $75.2 billion in 2024, then increased by 8.58% to $81.6 billion in 2025, then increased by 10.01% to $89.8 billion in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $89.8 billion, $91.0 billion, and $81.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.